Bringing Stem Cell Cures to the Clinic: UC Davis GMP Facility

The FDA requires the use of a Good Manufacturing Practice (GMP) facility for taking stem cell-based therapies into clinical trials. This GMP facility is a clean-room laboratory that ensures the therapeutic products will be safe and contamination-free for patients.

In Spring 2008, CIRM gave $272 million for the construction of twelve stem cell research facilities in California. The University of California, Davis was one of the recipients of this Major Facilities grant. Their $20 million award is supporting construction of the new Institute for Regenerative Cures. This 60,000 square foot building will include a state-of-the-art GMP facility.

Jan Nolta is the director of the UC Davis stem cell program and Institute for Regenerative Cures. Gerhard Bauer is director of the UC Davis GMP laboratory and is an assistant professor at the UC Davis school of medicine.

Category:

Science & Technology

Tags:

• cirm
• california
• institute
• regenerative
• medicine
• stem
• cell
• research
• embryonic
• university
• davis
• gmp
• good
• manufacturing
• practice
• proposition
• 71
• therapy
• nolta
• gerhard

[luciagillis]

Can this cure blindness?

[henrykitoy007]

stell cell means found in embryo are the bodys primordial cells. they can grow into every human tissue. bone muscle blood and brain and stem cell used in clone humans by splitting entire embryo early in development

[prizrenasi78]

Realy amazing!

Manny greateings CIRM.

[tmpren]

Thank you for everything you are doing; it is truly amazing.

You give HOPE to so many ~

Karen (Emily's Aunt)